Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
D000230:Adenocarcinoma / Q000532:radiotherapy; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy*; D018288:Carcinoma, Small Cell / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy; D008920:Misonidazole / Q000627:therapeutic use*; D009062:Mouth Neoplasms / Q000532:radiotherapy; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009960:Oropharynx; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D012189:Retrospective Studies
D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D008920:Misonidazole